China Remains at Risk to Future MonkeyPox Outbreaks.

GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox. The World Health Organization just updated global...

GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Are we happy, you betcha! We just got back from St Croix where the team from the Beverage Stock Review visited the Mutiny Island Vodka...

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier 44-page report, we printed it out and...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded...

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview) Society Pass (SOPA) $1.27. Recent High $6.75. (InternetStockReview) Okay we're...

Vaccine Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday after Peter Marks, a top Food and Drug Administration official,...

Adding Bavarian Nordic (BVNRY) to Watch List $7.36. Freeze Dries its MPOX Vaccine!

This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to the 2020 Biotech Watch List and...

GeoVax (GOVX) Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed...

EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions LIVE QUOTE ATLANTA, GA - July...

TWO DOUBLES, From the Same Stock! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding...

Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go again. With our 4th billion...
DAVID DODD GEOVAX

Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture

BioPharm David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States. Editor's Note: The views an opinions expressed...

Latest article

Fairchild Gold Corp., Presenting at Palm Beach Investor Roadshow.

Vancouver, British Columbia and Las Vegas, Nevada--(Institutional Analyst - April 8th, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"),...

Precious Metals Analyst | Mark Reichman | Noble Capital

Mark Reichman Senior Research Analyst, Industrials and Basic Industries BIO Mark joined Noble as a senior research analyst with coverage responsibility in the Industrials and Basic Industries...